Terms: = Brain cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
133 results:
1. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
2. Intratumoral histological and molecular heterogeneity in an adult diffuse glioma.
Yogaretnam T; Heffernan J; Leung R; Heeney C; Walsh A; Looby S; Caird J; Brett FM
Clin Neuropathol; 2024; 43(2):60-64. PubMed ID: 38495012
[TBL] [Abstract] [Full Text] [Related]
3. Intracranial dural arteriovenous fistulas: association with cerebral venous thrombosis, baseline aggressiveness, and clinical outcomes. A retrospective multicenter study on 263 consecutive patients and literature review.
Cohen C; Lenck S; Talbi A; Ifergan H; Premat K; Boulouis G; Janot K; Boch AL; Magni C; Herbreteau D; Sourour N; Shotar E; Barrot V; Clarençon F
Neurosurg Focus; 2024 Mar; 56(3):E9. PubMed ID: 38428003
[TBL] [Abstract] [Full Text] [Related]
4. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract] [Full Text] [Related]
5. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV
Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033
[TBL] [Abstract] [Full Text] [Related]
6. Interplay between atrx and IDH1 mutations governs innate immune responses in diffuse gliomas.
Hariharan S; Whitfield BT; Pirozzi CJ; Waitkus MS; Brown MC; Bowie ML; Irvin DM; Roso K; Fuller R; Hostettler J; Dharmaiah S; Gibson EA; Briley A; Mangoli A; Fraley C; Shobande M; Stevenson K; Zhang G; Malgulwar PB; Roberts H; Roskoski M; Spasojevic I; Keir ST; He Y; Castro MG; Huse JT; Ashley DM
Nat Commun; 2024 Jan; 15(1):730. PubMed ID: 38272925
[TBL] [Abstract] [Full Text] [Related]
7. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
8. Radiotherapy for brain Metastases Near the End of Life: Characterizing Patients and Tumor Features.
Silva SB; Barreto RB; de Oliveira FCG; Martin GSD; Takiguchi OMY; Chirichela IA; Miranda MHF; Bodnar D; Alves Reis LA; Pereira GCB; Miranda IL; Pereira BR; Arruda GV; Peria FM
JCO Glob Oncol; 2023 Sep; 9():e2300143. PubMed ID: 37883725
[TBL] [Abstract] [Full Text] [Related]
9. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract] [Full Text] [Related]
10. Comparative effectiveness of endoscopic and microscopic adenoma removal in acromegaly.
Vassilyeva N; Mena N; Kirov K; Diatlova E
Front Endocrinol (Lausanne); 2023; 14():1128345. PubMed ID: 37766690
[TBL] [Abstract] [Full Text] [Related]
11. Epileptic versus neuro-oncological focus of management in pediatric patients with concurrent primary brain lesion and seizures: a systematic review.
Gruber MD; Pindrik J; Damante M; Schulz L; Shaikhouni A; Leonard JR
J Neurosurg Pediatr; 2023 Nov; 32(5):576-583. PubMed ID: 37728409
[TBL] [Abstract] [Full Text] [Related]
12. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821
[TBL] [Abstract] [Full Text] [Related]
13. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
[TBL] [Abstract] [Full Text] [Related]
14. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
Jain S; Gupta P; Shankar KB; Singh R; Siraj F
J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
[TBL] [Abstract] [Full Text] [Related]
16. Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn's disease in Chinese population.
Mao J; Chao K; Jiang FL; Ye XP; Yang T; Li P; Zhu X; Hu PJ; Zhou BJ; Huang M; Gao X; Wang XD
World J Gastroenterol; 2023 Jun; 29(24):3855-3870. PubMed ID: 37426324
[TBL] [Abstract] [Full Text] [Related]
17. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
[TBL] [Abstract] [Full Text] [Related]
18. Multimodal-based machine learning strategy for accurate and non-invasive prediction of intramedullary glioma grade and mutation status of molecular markers: a retrospective study.
Ma C; Wang L; Song D; Gao C; Jing L; Lu Y; Liu D; Man W; Yang K; Meng Z; Zhang H; Xue P; Zhang Y; Guo F; Wang G
BMC Med; 2023 May; 21(1):198. PubMed ID: 37248527
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of Ki-67 labeling index, atrx mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
[TBL] [Abstract] [Full Text] [Related]
20. Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging.
Hollon T; Jiang C; Chowdury A; Nasir-Moin M; Kondepudi A; Aabedi A; Adapa A; Al-Holou W; Heth J; Sagher O; Lowenstein P; Castro M; Wadiura LI; Widhalm G; Neuschmelting V; Reinecke D; von Spreckelsen N; Berger MS; Hervey-Jumper SL; Golfinos JG; Snuderl M; Camelo-Piragua S; Freudiger C; Lee H; Orringer DA
Nat Med; 2023 Apr; 29(4):828-832. PubMed ID: 36959422
[TBL] [Abstract] [Full Text] [Related]
[Next]
